Back to search

Article

Advancing Non-Small Cell Lung Cancer Treatment: A Case Series on Pemetrexed Intrathecal Chemotherapy Monitored Through Circulating Tumor DNA in Cerebrospinal Fluid

2024-06-11

Abstract excerpt

<title>Abstract</title> <p>Intrathecal pemetrexed (IP) treatment represents a promising approach for managing leptomeningeal metastasis (LM) in cancer patients. However, a standardized and measurable method to evaluate the efficacy of IP for non-small cell lung cancer (NSCLC) patients with LM is currently lacking. This report describes three NSCLC-LM cases treated with IP following progression with tyrosine kinas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c8f5026-1dba-5601-a052-fb0c0a10f4f7
DOI
10.21203/rs.3.rs-4482413/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Advancing Non-Small Cell Lung Cancer Treatment: A Case Series on Pemetrexed Intrathecal Chemotherapy Monitored Through Circulating Tumor DNA in Cerebrospinal FluidDOI 10.21203/rs.3.rs-4482413/v1
Select a neighboring publication to make it the new centre.